Who owns Crinetics Pharmaceuticals, Inc.?
Institutional ownership of CRNX from SEC Form 13F filings across 194 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
194
13F holders
$2.83B
value, 2026 filers
77.4%
of shares outstanding (82.0M sh)
40
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of CRNX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 15.8M | $592.7M | 0.0% | 14.9% | +0.5% |
| 2 | BlackRock, Inc. | 9.8M | $365.2M | 0.0% | 9.2% | +15.1% |
| 3 | WELLINGTON MANAGEMENT GROUP LLP | 7.1M | $266.8M | 0.0% | 6.7% | -12.6% |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 6.2M | $232,480 | 0.0% | 5.9% | +16.0% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.8M | $180.8M | 0.0% | 4.6% | +4.2% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 4.7M | $177.6M | 0.0% | 4.5% | -49.2% |
| 7 | Jupiter Topco LLCNEW | 4.6M | $170.5M | 0.1% | 4.3% | new |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.7M | $102.1M | 0.0% | 2.6% | +10.0% |
| 9 | Pictet Asset Management Holding SA | 2.1M | $77.6M | 0.1% | 2% | +10.1% |
| 10 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.7M | $62.8M | 0.1% | 1.6% | -2.2% |
| 11 | JPMORGAN CHASE & CO | 1.4M | $50.6M | 0.0% | 1.3% | +3.0% |
| 12 | MORGAN STANLEY | 1.3M | $50.1M | 0.0% | 1.3% | +45.5% |
| 13 | BANK OF AMERICA CORP /DE/ | 1.3M | $49.9M | 0.0% | 1.3% | +86.2% |
| 14 | AMERICAN CENTURY COMPANIES INC | 1.3M | $47.2M | 0.0% | 1.2% | +19.9% |
| 15 | MONTANOVA CAPITAL, LLC | 1.2M | $44.4M | 0.8% | 1.1% | +13.6% |
| 16 | MARSHALL WACE, LLP | 1.1M | $42.2M | 0.0% | 1.1% | +64.7% |
| 17 | GOLDMAN SACHS GROUP INC | 1.1M | $41.3M | 0.0% | 1% | +75.9% |
| 18 | NORTHERN TRUST CORP | 974,781 | $36.5M | 0.0% | 0.9% | +15.9% |
| 19 | Sixth Street Partners Management Company, L.P.NEW | 877,643 | $32.8M | 5.7% | 0.8% | new |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 877,643 | $32.8M | 0.0% | 0.8% | +5.3% |
| 21 | Aberdeen Group plc | 820,395 | $30.7M | 0.0% | 0.8% | 0.0% |
| 22 | Candriam S.C.A. | 819,032 | $30.6M | 0.1% | 0.8% | -1.4% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 754,436 | $28.2M | 0.0% | 0.7% | +6.5% |
| 24 | Fisher Asset Management, LLC | 741,553 | $27.7M | 0.0% | 0.7% | -2.8% |
| 25 | UBS Group AG | 561,165 | $21.0M | 0.0% | 0.5% | -1.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.